15.02.2012 • News

DuPont Starts Unit Auction, May Fetch $4 Billion

Chemical maker DuPont has started the auction of its car paint business, which could bring in more than $4 billion and has drawn early interest from a number of private equity firms, according to sources familiar with the matter.

DuPont's adviser on the deal, Credit Suisse Group, has sent out financial materials related to the unit to potentially interested parties, the sources said.

Reuters and other news organizations reported in October that DuPont was considering the sale of the unit, and several buyout firms have been preparing for the auction since late last year. The unit could also attract interest from other chemical companies.

Private equity firms find the unit especially attractive as they believe costs can easily be cut to make it more profitable, the sources said.

Still, it remains expensive for buyout firms to secure financing, which hurts returns and could makes buyout firms shy about offering top dollar for businesses.

Private equity firms Blackstone Group, Clayton Dubilier & Rice and Advent International are considering bids, sources familiar with the matter said.

Reuters reported in December that KKR & Co, Bain Capital, TPG Capital and Onex Corp had already made inquiries about the sale.

The performance coatings business primarily sells to Maaco and other auto paint refinishers. Ford Motor and General Motors are also key customers, though selling to so-called original equipment manufacturers is not as lucrative.

DuPont, Credit Suisse, Blackstone and CD&R declined to comment on the matter. Advent could not be immediately reached for comment.

 

 

From Lab to Market Challenge

Vote Now: Germany's Most Promising Chemistry Start-ups
Choose your favourite among the finalists

Vote Now: Germany's Most Promising Chemistry Start-ups

The "From Lab to Market Challenge" brings together the most promising founders from chemistry, materials science, and industrial biotechnology. Starting June 1st, you can cast your public vote for the finalists on CHEManager.com — before the award ceremony with €10,000 in prizes takes place on June 25th.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read